Proteomics

Dataset Information

0

Optimized liquid and gas phase fractionations increase HLA-peptidome coverage for primary cell and tissue samples


ABSTRACT: Mass spectrometry is the most effective method to directly identify peptides presented on HLA molecules. However, current standard approaches often require billions of cells for input material to achieve high coverage of the immunopeptidome and are therefore not compatible with the often limiting amounts of tissue available from clinical tumor samples. Here, we evaluated microscaled basic reversed-phase fractionation to separate HLA peptide samples off-line followed by ion mobility coupled to LC-MS/MS for analysis. The combination of these two separation methods enabled identification of 20% to 50% more peptides compared to samples analyzed without either prior fractionation or use of ion mobility. We demonstrate coverage of HLA immunopeptidomes with up to 8,107 distinct peptides starting with as few as 50 million cells or 150 milligrams of wet weight tumor tissue. This increased sensitivity can improve HLA binding prediction algorithms and enable detection of clinically relevant epitopes such as neoantigens

ORGANISM(S): Homo Sapiens

SUBMITTER: Hasmik Keshishian  

PROVIDER: PXD027165 | panorama | Mon Aug 30 00:00:00 BST 2021

REPOSITORIES: PanoramaPublic

altmetric image

Publications


MS is the most effective method to directly identify peptides presented on human leukocyte antigen (HLA) molecules. However, current standard approaches often use 500 million or more cells as input to achieve high coverage of the immunopeptidome, and therefore, these methods are not compatible with the often limited amounts of tissue available from clinical tumor samples. Here, we evaluated microscaled basic reversed-phase fractionation to separate HLA peptide samples offline followed by ion mob  ...[more]

Similar Datasets

2021-07-01 | MSV000087743 | MassIVE
2023-03-09 | MSV000091456 | MassIVE
2023-02-21 | PXD033710 | Pride
2024-08-09 | PXD046072 | Pride
2023-07-20 | PXD039174 | Pride
2024-08-02 | PXD039066 | Pride
2023-11-21 | PXD038782 | Pride
2022-08-12 | PXD034640 | Pride
2023-08-18 | PXD039343 | Pride
2023-08-25 | PXD042416 | Pride